Fact checked by Nick Blackmer GLP-1 medications like Ozempic and Wegovy have become popular for helping people lose weight or ...

Researchers have developed and are testing a small, implanted gastric balloon that people can inflate or deflate to feel full ...

The push to develop the first oral GLP-1 receptor drug for obesity is heating up, as four phase 3 drugs race to become the first approved oral treatment for obesity, Global Data reported Dec. 2. Here ...

The ADA recommended doctors avoid prescribing unapproved, off-brand versions of drugs like Wegovy, wading into a dispute that ...

About 20% of patients — as many as 1 in 5 — may not respond well to medications like Mounjaro and Wegovy, according to ...

In a new guidance statement, the American Diabetes Association advises against the use of unapproved products, warning of ...

The new class of GLP-1 weight loss drugs have been blockbusters since they arrived on the market a few years ago. These ...

While B-ALL is the most common childhood cancer and one of the most treatable, some patients face grim outcomes after they ...

Ozempic and other GLP-1 agonist medications have risen in popularity over the last few years due to their touted blood sugar management and weight-loss effects. However, some supp ...

If you're in a relationship that faces struggles with weight and are considering GLP-1 medications like Ozempic, consider ...

Brand companies who own GLP-1 products have been pushing the Food and Drug Administration (FDA) to limit their compounding. On August 28, 2024, ...

Medicare currently only covers these drugs for people who are diagnosed with diabetes or cardiovascular disease with obesity, ...